Science In (UK) Today
| SIS Stock | 28.50 0.00 0.00% |
PerformanceOK
| Odds Of DistressAverage
|
Science In is trading at 28.50 as of the 20th of March 2025, a No Change since the beginning of the trading day. The stock's lowest day price was 28.1. Science In has 51 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
Business Domain Food, Beverage & Tobacco | Category Consumer Defensive | Classification Consumer Staples |
Science In is entity of United Kingdom. It is traded as Stock on LSE exchange. The company has 230.23 M outstanding shares. More on Science in Sport
Moving together with Science Stock
Moving against Science Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Science Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Science In's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Science In or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO Director | Stephen Moon | ||||
| Thematic Ideas | (View all Themes) | ||||
| Business Concentration | Packaged Foods & Meats, Food, Beverage & Tobacco, Consumer Defensive, Sport Products, Aluminum, Consumer Staples, Food Products, Packaged Foods, Consumer Defensive (View all Sectors) | ||||
Science In's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Science In's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsScience In can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Science In's financial leverage. It provides some insight into what part of Science In's total assets is financed by creditors.
| |||||
Science in Sport (SIS) is traded on London Exchange in UK and employs 330 people. Science In is listed under Packaged Foods & Meats category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 65.61 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Science In's market, we take the total number of its shares issued and multiply it by Science In's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Science in Sport operates under Food Products sector and is part of Consumer Staples industry. The entity has 230.23 M outstanding shares.
Science In generates positive cash flow from operations, but has no cash available
Check Science In Probability Of Bankruptcy
Ownership AllocationScience in Sport shows a total of 230.23 Million outstanding shares. Over half of Science In's outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Science in Sport. Please watch out for any change in the institutional holdings of Science In as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Science Ownership Details
Science in Sport Risk Profiles
Although Science In's alpha and beta are two of the key measurements used to evaluate Science In's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.8365 | |||
| Semi Deviation | 0.9917 | |||
| Standard Deviation | 1.53 | |||
| Variance | 2.34 |
Science Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Science In without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
| All Next | Launch Module |
Science In Corporate Management
Elected by the shareholders, the Science In's board of directors comprises two types of representatives: Science In inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Science. The board's role is to monitor Science In's management team and ensure that shareholders' interests are well served. Science In's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Science In's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Bernadette UdeWetherell | Chief Officer | Profile | |
| Megan Blaylock | Chief Officer | Profile | |
| Muna Khan | Chief Officer | Profile | |
| Andy Bott | Chief Officer | Profile |
Other Information on Investing in Science Stock
Science In financial ratios help investors to determine whether Science Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Science with respect to the benefits of owning Science In security.